Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
43
AZTA Quote, Financials, Valuation and Earnings
Last price:
$34.60
Seasonality move
:
12.23%
Day range:
$34.31 - $34.93
52-week range:
$23.91 - $55.64
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
2.67x
P/B ratio:
0.92x
Volume:
672K
Avg. volume:
791.4K
1-year change:
-31.32%
Market cap:
$1.6B
Revenue:
$593.8M
EPS (TTM):
-$1.22
Analysts' Opinion
-
Consensus RatingAzenta, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 1 Buy rating, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $40.17, Azenta, Inc. has an estimated upside of 15.75% from its current price of $34.51.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $34.00 representing 100% downside risk from its current price of $34.51.
Fair Value
-
According to the consensus of 5 analysts, Azenta, Inc. has 15.75% upside to fair value with a price target of $40.17 per share.
AZTA vs. S&P 500
-
Over the past 5 trading days, Azenta, Inc. has underperformed the S&P 500 by -0.29% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Azenta, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Azenta, Inc. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter Azenta, Inc. reported revenues of $159.2M.
Earnings Growth
-
Azenta, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Azenta, Inc. reported earnings per share of $1.11.
Enterprise value:
1.3B
EV / Invested capital:
0.73x
Price / LTM sales:
2.67x
EV / EBIT:
--
EV / Revenue:
2.21x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
34.25x
Price / Operating cash flow:
41.33x
Enterprise value / EBITDA:
28.15x
Gross Profit (TTM):
$270M
Return On Assets:
1.21%
Net Income Margin (TTM):
4.16%
Return On Equity:
1.44%
Return On Invested Capital:
1.39%
Operating Margin:
1.85%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $665.1M | $573M | $594.1M | $150.6M | $159.2M | |
| Gross Profit | $233.3M | $251M | $270M | $68.5M | $72.3M | |
| Operating Income | -$85.6M | -$25.6M | -$10.7M | $6.1M | $2.9M | |
| EBITDA | -$14K | $42.3M | $46.6M | $29.9M | $17.4M | |
| Diluted EPS | -$0.21 | -$3.01 | -$1.22 | -$0.14 | $1.11 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $777.4M | $2.5B | $1.4B | $833M | $708.3M | |
| Total Assets | $1.8B | $3.7B | $2.9B | $2.1B | $2.1B | |
| Current Liabilities | $345.1M | $230.5M | $210.9M | $206.1M | $237.7M | |
| Total Liabilities | $494.2M | $352.7M | $351.2M | $331M | $330.7M | |
| Total Equity | $1.3B | $3.4B | $2.5B | $1.8B | $1.7B | |
| Total Debt | $95.1M | $49.4M | $62.5M | $58.2M | $52.8M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $17.5M | $49.7M | $72.2M | $17.6M | $2.2M | |
| Cash From Investing | $431.4M | $224.7M | -$90.5M | $198M | $826K | |
| Cash From Financing | -$844.1M | -$659.2M | -$9.6M | -$247.5M | $817K | |
| Free Cash Flow | -$21.9M | $12.4M | $38.3M | $8.2M | -$5.7M | |
AZTA
Sector
Market Cap
$1.6B
$28.1M
Price % of 52-Week High
62.18%
51.39%
Dividend Yield
0%
0%
Shareholder Yield
-0.04%
-1.49%
1-Year Price Total Return
-30.64%
-17.13%
Beta (5-Year)
1.288
0.518
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$34.67
200-day SMA
Buy
Level
$31.02
Bollinger Bands (100)
Buy
Level
29.1 - 33.84
Chaikin Money Flow
Buy
Level
53.3M
20-day SMA
Sell
Level
$35.39
Relative Strength Index (RSI14)
Buy
Level
51.65
ADX Line
Buy
Level
24.28
Williams %R
Buy
Level
-80.5492
50-day SMA
Buy
Level
$32.76
MACD (12, 26)
Buy
Level
0.53
25-day Aroon Oscillator
Buy
Level
60
On Balance Volume
Neutral
Level
81M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.8993)
Buy
CA Score
(Annual)
Level (1.1837)
Buy
Beneish M-Score
(Annual)
Level (-2.6091)
Buy
Momentum Score
Level (3)
Buy
Ohlson Score
Level (-3.3562)
Buy
Piotroski F Score
(Annual)
Level (7)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (7)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company offers a suite of reliable cold-chain sample management solutions and multiomics services supporting drug development, clinical research, and advanced cell therapies for pharmaceutical, biotechnology, academic, and healthcare institutions globally. It operates through the following segments: Sample Management Solutions and Multiomics. The Sample Management Solutions segment provides end-to-end sample management products and services, including Sample Repository Services (SRS). Its core products include automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled-rate thawing devices. The Multiomics segment delivers genomic and other sample analysis services, including gene sequencing, gene synthesis, and related services. The company was founded in 1978 and is headquartered in Burlington, MA.
Stock Forecast FAQ
In the current month, AZTA has received 1 Buy ratings 4 Hold ratings, and 0 Sell ratings. The AZTA average analyst price target in the past 3 months is $40.17.
-
Where Will Azenta, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Azenta, Inc. share price will rise to $40.17 per share over the next 12 months.
-
What Do Analysts Say About Azenta, Inc.?
Analysts are divided on their view about Azenta, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Azenta, Inc. is a Sell and believe this share price will drop from its current level to $34.00.
-
What Is Azenta, Inc.'s Price Target?
The price target for Azenta, Inc. over the next 1-year time period is forecast to be $40.17 according to 5 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is AZTA A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Azenta, Inc. is a Hold. 4 of 5 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of AZTA?
You can purchase shares of Azenta, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Azenta, Inc. shares.
-
What Is The Azenta, Inc. Share Price Today?
Azenta, Inc. was last trading at $34.60 per share. This represents the most recent stock quote for Azenta, Inc.. Yesterday, Azenta, Inc. closed at $34.51 per share.
-
How To Buy Azenta, Inc. Stock Online?
In order to purchase Azenta, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get AZTA Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
AZTA
Sector
P/E ratio
--
23.89x
PEG ratio
-0.01x
-0.01x
P/B ratio
0.92x
1.81x
Price / LTM sales
2.67x
1.59x
Growth Metrics
AZTA
Sector
Revenue growth
5.7%
4.62%
Earnings growth
901.01%
11.06%
Revenue (5-year growth)
8.85%
6.5%
Earnings forecast
$0.20
-$0.21
Profitability
AZTA
Sector
Profitability FY 2025
$270.3M
$3.6M
Return on invested capital
1.39%
-31.84%
Return on assets
1.21%
-27.96%
Return on equity
1.44%
-37.63%
Earnings Date
Last Earnings Date
Nov
21
Next Earnings Date
Feb
4
Estimated Next Earnings Date
Feb
20
Balance Sheet
AZTA
Sector
Total cash
$343.3M
$26.4M
Short term investments
$151.2M
$25.7M
Total assets
$2.1B
$76.9M
Long term debt
$52.8M
$3.3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
